Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study Investigating the Safety and Efficacy of rhPTH(1-84) in Subjects With Hypoparathyroidism

NCT03364738 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT03364738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03364738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study Investigating the Safety and Efficacy of rhPTH(1-84) in Subjects With Hypoparathyroidism
Lead sponsor
Shire
Phase
Phase 3
Overall status
Terminated
Start date
September 26, 2018
Completion date
April 14, 2020
Enrollment
22 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hypoparathyroidism